AJW-200

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAJW-200
Drug Alias NameAJW-200
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionVon willebrand factor inhibitors
TargetsVon willebrand factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAjinomoto Co Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A